Glutathione biosynthesis enzymes and reactive oxygen species (see is_incorrect and description for clarity)

The phrase "Glutathione biosynthesis & Reactive Oxygen Species" does not denote a specific molecule or drug target, but instead refers to interconnected processes central to cell survival and stress adaptation. **Glutathione** is a ubiquitous tripeptide (γ-glutamyl-cysteinyl-glycine), acting as the primary low-molecular-mass antioxidant in cells, maintaining redox balance by neutralizing ROS[2][5]. Its biosynthesis relies on the enzymes glutamate–cysteine ligase and glutathione synthetase[2]. The relative levels of reduced (GSH) and oxidized (GSSG) glutathione are key indicators of cellular oxidative stress. **Reactive oxygen species** (ROS) collectively refers to highly reactive molecules, such as superoxide (O~2~^−^), hydrogen peroxide (H~2~O~2~), and hydroxyl radical (·OH), that can cause cellular damage but also act as signaling molecules[5]. Disruption of glutathione synthesis or excessive ROS generation underlies the pathology of many diseases, including cancer and neurodegeneration[6][7]. Therapeutic strategies may aim to modulate glutathione levels or ROS to affect disease outcomes, but because this query does not refer to a single molecular target, the entry is not well-formed for structured pharmacological databases. Key Note: This entry is **not a single molecule, enzyme, or receptor, and should not be used as a canonical molecular target**. For structured data, it should be split into individual entries such as "Glutamate–cysteine ligase" (the rate-limiting enzyme in glutathione synthesis), "Glutathione synthetase", or "Reactive oxygen species (molecule class)" if those entities are of interest[2][5].

Other names

Glutathione metabolismROS detoxification enzymesAntioxidant defense system

Enzyme inhibition to deplete glutathione (sensitizes cells to ROS and induces apoptosis); Antioxidant supplementation (raises glutathione levels, reduces oxidative damage); Nanocatalysts that deplete glutathione and elevate ROS for anti-tumor therapy.